Edgestream Partners L.P. Has $818,000 Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Edgestream Partners L.P. increased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 29.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,025 shares of the company’s stock after buying an additional 2,299 shares during the quarter. Edgestream Partners L.P.’s holdings in HealthEquity were worth $818,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Cape Investment Advisory Inc. bought a new position in shares of HealthEquity during the fourth quarter valued at $27,000. Rise Advisors LLC acquired a new position in HealthEquity in the first quarter valued at about $28,000. McGlone Suttner Wealth Management Inc. bought a new stake in HealthEquity during the fourth quarter worth about $29,000. YHB Investment Advisors Inc. acquired a new stake in shares of HealthEquity during the first quarter worth approximately $40,000. Finally, Fidelis Capital Partners LLC bought a new position in shares of HealthEquity in the first quarter valued at approximately $42,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. JPMorgan Chase & Co. increased their price target on HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 2nd. Wells Fargo & Company raised their target price on HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, June 20th. Bank of America reaffirmed a “buy” rating and issued a $105.00 price target on shares of HealthEquity in a report on Wednesday, July 3rd. Barrington Research increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. Finally, KeyCorp boosted their target price on shares of HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 5th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.67.

HealthEquity Trading Down 2.1 %

Shares of HealthEquity stock traded down $1.68 during trading on Wednesday, reaching $77.11. 120,575 shares of the company were exchanged, compared to its average volume of 616,969. The business has a 50-day moving average price of $81.34 and a 200-day moving average price of $79.87. The firm has a market capitalization of $6.71 billion, a price-to-earnings ratio of 85.64, a P/E/G ratio of 1.27 and a beta of 0.57. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. HealthEquity, Inc. has a twelve month low of $61.50 and a twelve month high of $88.26.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, June 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.08. The company had revenue of $287.60 million during the quarter, compared to analyst estimates of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. Sell-side analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Insider Activity at HealthEquity

In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the stock in a transaction on Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the sale, the chief executive officer now directly owns 232,176 shares in the company, valued at $19,231,138.08. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other HealthEquity news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the sale, the director now directly owns 6,070 shares in the company, valued at approximately $497,072.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon Kessler sold 32,326 shares of the stock in a transaction on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the sale, the chief executive officer now directly owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,511 shares of company stock worth $3,519,346. 2.20% of the stock is currently owned by company insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.